1. Home
  2. HRTX vs NCZ Comparison

HRTX vs NCZ Comparison

Compare HRTX & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRTX
  • NCZ
  • Stock Information
  • Founded
  • HRTX 1983
  • NCZ 2003
  • Country
  • HRTX United States
  • NCZ United States
  • Employees
  • HRTX N/A
  • NCZ N/A
  • Industry
  • HRTX Biotechnology: Pharmaceutical Preparations
  • NCZ Finance Companies
  • Sector
  • HRTX Health Care
  • NCZ Finance
  • Exchange
  • HRTX Nasdaq
  • NCZ Nasdaq
  • Market Cap
  • HRTX 242.0M
  • NCZ 228.3M
  • IPO Year
  • HRTX 1987
  • NCZ N/A
  • Fundamental
  • Price
  • HRTX $1.33
  • NCZ $13.81
  • Analyst Decision
  • HRTX Strong Buy
  • NCZ
  • Analyst Count
  • HRTX 2
  • NCZ 0
  • Target Price
  • HRTX $4.50
  • NCZ N/A
  • AVG Volume (30 Days)
  • HRTX 1.6M
  • NCZ 533.0K
  • Earning Date
  • HRTX 11-11-2025
  • NCZ 01-01-0001
  • Dividend Yield
  • HRTX N/A
  • NCZ 12.16%
  • EPS Growth
  • HRTX N/A
  • NCZ N/A
  • EPS
  • HRTX N/A
  • NCZ N/A
  • Revenue
  • HRTX $149,694,000.00
  • NCZ N/A
  • Revenue This Year
  • HRTX $10.62
  • NCZ N/A
  • Revenue Next Year
  • HRTX $12.99
  • NCZ N/A
  • P/E Ratio
  • HRTX N/A
  • NCZ N/A
  • Revenue Growth
  • HRTX 9.78
  • NCZ N/A
  • 52 Week Low
  • HRTX $1.04
  • NCZ $2.50
  • 52 Week High
  • HRTX $2.68
  • NCZ $3.15
  • Technical
  • Relative Strength Index (RSI)
  • HRTX 49.45
  • NCZ 60.45
  • Support Level
  • HRTX $1.29
  • NCZ $13.57
  • Resistance Level
  • HRTX $1.37
  • NCZ $13.72
  • Average True Range (ATR)
  • HRTX 0.06
  • NCZ 0.19
  • MACD
  • HRTX 0.02
  • NCZ -0.02
  • Stochastic Oscillator
  • HRTX 73.68
  • NCZ 50.77

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

About NCZ Virtus Convertible & Income Fund II of Beneficial Interest

Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. The investment objective of the company is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas, and consumable fuels and others.

Share on Social Networks: